Aperio Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Aperio Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-17,267	Closed	-$712K	–	2075
2015 Q2	$712K	Buy	17,267 +2,983	+21%	+$107K	0.01%	1134
2015 Q1	$503K	Buy	14,284 +339	+2%	+$11.5K	0.01%	1275
2014 Q4	$448K	Buy	+13,945	New	+$403K	0.01%	1285

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Aperio Group's BRLI Position: Q3 2015 in Review

Aperio Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 17,267 shares — an estimated $712K sold.

Aperio Group first reported a position in BRLI in Q4 2014 and held it in 3 quarters. The position peaked at $712K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Aperio Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Aperio Group sold 17,267 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $712K.
Aperio Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2014 and held it in 3 quarters.
Aperio Group's BIO-REFERENCE LABS INC-NEW- position peaked at $712K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Aperio Group's 13F filing for Q3 2015, filed 19 Oct 2015.